EXOZ vs TECH · rev $70.1K vs P/E 65, rev $1.22B
eXoZymes, Inc. (EXOZ) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
eXoZymes, Inc. (EXOZ) is a biotechnology company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported EXOZ revenue for 2023-12-31 was $70.1K. Net income was -$2.0M. Revenue was down 1.0% from 2023-09-30 to 2023-12-31. EXOZ currently screens at market cap $83.5M.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
EXOZ currently screens at market cap $83.5M. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the EXOZ and TECH stock pages for the full models.
Not investment advice.